Dicerna Pharmaceuticals To Present At The 2015 Leerink Global Healthcare Conference

Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics targeting genetically defined oncology and inherited rare diseases, today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will present at the 2015 Leerink Global Healthcare Conference. The presentation will take place at the Waldorf Astoria on Wednesday, February 11, 2015 at 1:00 p.m. ET in New York City.

Help employers find you! Check out all the jobs and post your resume.